Cell and Gene Therapy, Leadership December 07, 2023 Ian McCubbin receives Peter Dunnill award at bioProcessUK
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing November 28, 2023 RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration
Cell and Gene Therapy, Leadership October 04, 2023 RoslinCT to Present at 2023 Cell & Gene Meeting on the Mesa
Cell and Gene Therapy, Leadership October 03, 2023 RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
Cell and Gene Therapy, SAB August 17, 2023 RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board
Cell Therapy, cGMP Manufacturing June 05, 2023 RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings
Cell and Gene Therapy, Integration May 30, 2023 RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License for their cGMP Manufacturing facilities in Edinburgh, UK